`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`SAMSUNG BIOEPIS CO., LTD.
`Petitioner,
`
`v.
`
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner.
`
`Patent No. 11,253,572
`
`_______________
`
`Inter Partes Review No. IPR2023-00884
`____________________________________________________________
`
`PATENT OWNER’S MOTION FOR PRO HAC VICE ADMISSION OF
`DARALYN J. DURIE UNDER 37 C.F.R. § 42.10(c)
`
`
`
`
`
`
`IPR2023-00884
`
`I.
`
`Relief Requested
`
`
`
`Pursuant to 37 C.F.R. § 42.10, Patent Owner Regeneron Pharmaceuticals,
`
`Inc., requests that the Board admit Daralyn J. Durie pro hac vice in this
`
`proceeding.
`
`II.
`
`Statement of Facts Showing Good Cause for the Board to Recognize
`Counsel Pro Hac Vice During the Proceeding
`
`In accordance with 37 C.F.R. § 42.10(c), the Board may recognize counsel
`
`pro hac vice during a proceeding, subject to the conditions set forth therein, and
`
`any others that the Board may impose. Patent Owner sets forth these facts in
`
`support of this motion:
`
`1.
`
`The undersigned contacted counsel for Petitioner (Quinn Emanuel
`
`Urquhart & Sullivan LLP), who indicated that Petitioner did not plan to oppose
`
`Ms. Durie’s admission pro hac vice.
`
`2.
`
`Lead counsel for Patent Owner, Regeneron Pharmaceuticals, Inc.,
`
`Adam Brausa, and Backup counsel, Rebecca Weires are registered practitioners.
`
`3.
`
`Daralyn J. Durie is an experienced litigator and has established
`
`familiarity with the subject matter at issue in this proceeding. Accompanying this
`
`motion is Exhibit 2061, the Declaration of Daralyn J. Durie in Support of this
`
`Motion for Admission Pro Hac Vice (“Durie Decl.”). In her declaration, Ms.
`
`Durie attests, among other things, that she is a member in good standing of the
`
`California Bar. Durie Decl. ¶¶ 1-2. Ms. Durie has never been subject to
`
`
`
`1
`
`
`
`IPR2023-00884
`
`
`
`suspensions or disbarments from practice, nor had applications for admission to
`
`practice denied, nor been subject to any sanctions or contempt citations by any
`
`court or administrative body. Durie Decl. ¶¶ 3-5.
`
`4. Ms. Durie has over 16 years of experience litigating patent cases
`
`involving biotechnology. Durie Decl. ¶ 9. As is relevant to this matter, Ms. Durie
`
`has litigated a number of cases relating to methods of treatment using antibodies.
`
`Id. In addition, Ms. Durie’s familiarity with the subject matter at issue in this
`
`proceeding is demonstrated by her review of the ’572 Patent, all cited prior art, and
`
`the IPR petition in this matter. Durie Decl. ¶ 10.
`
`5.
`
`In her declaration, Ms. Durie also attests to her admission to practice
`
`in other courts, as well as each of the required items set forth by 37 C.F.R.
`
`§42.10(c) and Unified Patents, Inc. v. Parallel Iron, LLC, IPR2013-00639, Paper 7
`
`(PTAB Oct. 15, 2013). See Durie Decl. ¶¶ 1-10.
`
`III. Conclusion
`
`For the foregoing reasons, Patent Owner respectfully request that the Board
`
`admit Daralyn J. Durie pro hac vice in this proceeding.
`
`
`
`
`
`
`
`
`
`
`
`2
`
`
`
`IPR2023-00884
`
`Date: December 21, 2023
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`By: /Adam R. Brausa/
`Adam R. Brausa, Reg. No. 60,287
`MORRISON & FOERSTER LLP
`425 Market Street
`San Francisco, California 94105
`Tel: (415) 268-6053
`ABrausa@mofo.com
`
`Counsel for Patent Owner
`
`3
`
`
`
`IPR2023-00884
`
`Certificate of Service (37 C.F.R. § 42.6(e)(4))
`
`I hereby certify that the attached PATENT OWNER’S MOTION FOR PRO
`
`HAC VICE ADMISSION OF DARALYN J. DURIE UNDER 37 C.F.R. §
`
`42.10(c) and THE SUPPORTING DECLARATION OF DARALYN J. DURIE,
`
`were served on the date listed below via email (by agreement) upon the following
`
`counsel of record for Petitioner:
`
`Raymond N. Nimrod (Reg. No. 31,987)
`Matthew A. Traupman (Reg. No. 50,832)
`Landon Andrew Smith (Reg. No. 79,248)
`QUINN EMANUEL URQUHART
`& SULLIVAN, LLP
`51 Madison Ave., 22nd Floor
`New York, NY 10010
`Email: raynimrod@quinnemanuel.com
`Email: matthewtraupman@quinnemanuel.com
`Email: landonsmith@quinnemanuel.com
`Email: qe-samsungbioepis@quinnemanuel.com
`
`Dated: December 21, 2023
`
`/Adam R. Brausa/
`Adam R. Brausa, Reg. No. 60,287
`
`4
`
`